Teva teams with Sinclair IS on cancer-pain med; Indian pharma grows 16.9%, no slowdown seen;

@FiercePharma: Judge tosses all but one claim in Fosamax patient suit against Merck. No punitive damages allowed. News | Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) is teaming up with Sinclair IS Pharma to promote the cancer-pain drug episil in 5 European markets beginning in the fourth quarter of this year. Story

> India's pharmaceutical industry has posted recent growth of 16.9%, Business Monitor International says, and there's little chance of a slowdown. Report

> Impax Labs ($IPXL) confirmed it's challenging Avanir Pharmaceuticals' patent on its Nuedexta drug for pseudobulbar affect. Impax release

> A long-term study of UCB's epilepsy drug Vimpat showed 'sustained reduction' in partial onset seizures for up to 8 years. UCB release

> Eisai and Abbott Laboratories ($ABT) have launched their pancreatic enzyme replacement drug Lipacreon in Japan. Article

> Insight Pharmaceuticals is taking over McNeil's North American portfolio of Monistat-branded antifungal products. News

> Baxter's BioPharma Solutions business wrapped up an expansion at a plant in Halle, Germany, where it turns out cytotoxic products for contract customers. Item

> Perrigo ($PRGO) won FDA approval for its version of the skin disease treatment Extina foam, which posts annual sales of $10 million. Report

Biotech News

@FierceBiotech: New R&D culture at GSK forces a challenging showdown. News | Follow @FierceBiotech

@JohnCFierce: Argonne has begun construction of an advanced protein crystallization lab for drug research. Report | Follow @JohnCFierce

@RyanMFierce: Virtual drug discovery MT @BioWorld: "We're trying to digitalize biotech," says Zymeworks CEO after $187M deal with Merck Item | Follow @RyanMFierce

@MaureenFierce: Can targeted drugs save Big Pharma? Article May help wean Big Pharma off of big blockbusters. | Follow @MaureenFierce

> Amgen backs $30M venture round for IBS-focused Ardelyx. Details

> Analyst: Benlysta's shortcomings offer blockbuster opening for new lupus drugs. More

> OrbiMed launches $600M fund for royalty, debt deals. Article

> E&Y: India's biotech industry hits the fast lane. Story

> Argonne preps $34.5M drug research lab to support protein projects. Report

Drug Delivery News

> FDA gives orphan OK to Pluristem's delivery platform for Buerger's disease. More

> Unilife aims prefilled syringes at patients who self inject. Story

> Newer drug-eluting stents reduce restenosis by 38%, thrombosis by half. Report

> MonoSol, KemPharm partner on second ADHD thin-film drug. Details

> QLT reports successes with eye drug delivery, analyst skeptical. Article

> A more precise method of making micelles. News

Medical Device News

> Cardiox raises $8M in Series C. Report

> Lantos aims to help military, consumers with 3D ear-mapping. News

> S&N takeover rumors rekindled. Story

> B. Braun, CareFusion in patent disputes. Details

> Medtronic, NuVasive clash over patents. More

> GI dynamics raises $85 in Australian IPO. Article

And Finally... Pregnant women who dip snuff have babies with more breathing problems than smoking women do. Story

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.